✦ LIBER ✦

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

✍ Scribed by Hennie G Raterman, Saskia Vosslamber, Sander de Ridder…

Book ID: 120706109
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 401 KB
Volume: 14
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar3819

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between the type I interfer

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

✍ Rogier M. Thurlings; Marie Boumans; Janneke Tekstra; Joel A. van Roon; Koen Vos; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Blood memory B cells are disturbed and p

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

✍ Jérémie Sellam; Stéphanie Rouanet; Houria Hendel-Chavez; Karim Abbed; Jean Sibil 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

Response to rituximab in patients with r

Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system

✍ Maria J. H. Boumans; Rogier M. Thurlings; Danielle M. Gerlag; Koen Vos; Paul P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 2 views

The cellular immune response to influenz

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

✍ U. Arad; S. Tzadok; S. Amir; M. Mandelboim; E. Mendelson; I. Wigler; H. Sarbagil 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 661 KB

CCL19, a B Cell Chemokine, Is Related to

CCL19, a B Cell Chemokine, Is Related to the Decrease of Blood Memory B Cells and Predicts the Clinical Response to Rituximab in Patients With Rheumatoid Arthritis

✍ Sellam, Jérémie; Rouanet, Stéphanie; Hendel-Chavez, Houria; Miceli-Richard, Cori 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Association of the response to tumor nec

Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-β/α ratios in rheumatoid arthritis patients: A post hoc analysis of a predominantly Hispanic cohort

✍ Clio P. Mavragani; Dan T. La; William Stohl; Mary K. Crow 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views